Annual Alzheimer's clinical trials pipeline report shows increased reason for optimism
An annual review of clinical trials for Alzheimer's disease highlights a growing number of active trials—and drugs—in the development pipeline and offers optimism for the global effort to find a cure.
Jun 4, 2025
0
1









